Solomon and colleagues detected 13 NTRK fusions among 571 thyroid carcinomas (2.3%); pan-Trk IHC analysis showed 100% specificity but lower sensitivity (82%) for NTRK rearrangements [5]. This evidence concerns the gene NTRK1 and thyroid gland carcinoma.